23.20 USD
-0.68
2.85%
At close Feb 21, 4:00 PM EST
After hours
23.20
+0.00
0.00%
1 day
-2.85%
5 days
5.17%
1 month
8.01%
3 months
54.98%
6 months
7.56%
Year to date
30.85%
1 year
-42.43%
5 years
-22.64%
10 years
45.55%
 

About: Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.

Employees: 566

0
Funds holding %
of 7,139 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

179% more call options, than puts

Call options by funds: $8.57M | Put options by funds: $3.07M

1.85% more ownership

Funds ownership: 95.65% [Q3] → 97.51% (+1.85%) [Q4]

2% more capital invested

Capital invested by funds: $1.4B [Q3] → $1.43B (+$27.6M) [Q4]

8% less funds holding

Funds holding: 283 [Q3] → 261 (-22) [Q4]

21% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 96

24% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 71

67% less funds holding in top 10

Funds holding in top 10: 3 [Q3] → 1 (-2) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$23
1%
downside
Avg. target
$24
3%
upside
High target
$25
8%
upside

2 analyst ratings

positive
50%
neutral
50%
negative
0%
B of A Securities
Michael Cherny
67% 1-year accuracy
26 / 39 met price target
8%upside
$25
Buy
Maintained
11 Feb 2025
JP Morgan
Anne Samuel
50% 1-year accuracy
18 / 36 met price target
1%downside
$23
Neutral
Maintained
28 Jan 2025

Financial journalist opinion

Based on 6 articles about PGNY published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth
Neutral
GlobeNewsWire
1 week ago
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2024, after the close of the market on Thursday, February 27, 2025. The company will host a conference call at 4:45 p.m.
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report
Neutral
GlobeNewsWire
1 week ago
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Progyny, Inc. (NASDAQ: PGNY) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm
Positive
Zacks Investment Research
2 weeks ago
All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy
Positive
Zacks Investment Research
3 weeks ago
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report?
Neutral
GlobeNewsWire
3 weeks ago
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning Provides expecting parents with a concierge-level service model that delivers expert guidance, navigation and support for parental leave planning
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
Neutral
GlobeNewsWire
1 month ago
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building and women's health benefits solution, today announced the appointment of 30-year healthcare industry veteran Debra Morris to its board of directors, effective January 16, 2025.
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors
Neutral
Business Wire
1 month ago
Securities Fraud Investigation Into Progyny, Inc. (PGNY) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROGYNY, INC. (PGNY), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On September 18, 20.
Securities Fraud Investigation Into Progyny, Inc. (PGNY) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Neutral
Business Wire
1 month ago
Progyny, Inc. (PGNY) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Progyny, Inc. (“Progyny” or the “Company”) (NASDAQ: PGNY) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROGYNY, INC. (PGNY), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howa.
Progyny, Inc. (PGNY) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Neutral
PRNewsWire
1 month ago
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
BLOOMFIELD, Conn. , Jan. 13, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), today announced a new offering in collaboration with Progyny, Inc (Nasdaq: PGNY) that makes best-in-class fertility and family-building services accessible and equitable for more employers.
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services
Charts implemented using Lightweight Charts™